ProShare Advisors’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.7K | Sell |
35,782
-2,908
| -8% | -$7.94K | ﹤0.01% | 1884 |
|
|
2025
Q1 | $65K | Sell |
38,690
-9,118
| -19% | -$15.3K | ﹤0.01% | 1918 |
|
|
2024
Q4 | $77.9K | Buy |
47,808
+9,679
| +25% | +$15.8K | ﹤0.01% | 2116 |
|
|
2024
Q3 | $159K | Buy |
38,129
+11,603
| +44% | +$48.3K | ﹤0.01% | 1789 |
|
|
2024
Q2 | $145K | Sell |
26,526
-6,164
| -19% | -$33.7K | ﹤0.01% | 1598 |
|
|
2024
Q1 | $327K | Buy |
32,690
+4,210
| +15% | +$42.1K | ﹤0.01% | 1372 |
|
|
2023
Q4 | $116K | Buy |
28,480
+3,490
| +14% | +$14.2K | ﹤0.01% | 1759 |
|
|
2023
Q3 | $96.7K | Buy |
24,990
+471
| +2% | +$1.82K | ﹤0.01% | 1636 |
|
|
2023
Q2 | $146K | Buy |
24,519
+820
| +3% | +$4.89K | ﹤0.01% | 1617 |
|
|
2023
Q1 | $77.5K | Sell |
23,699
-3,513
| -13% | -$11.5K | ﹤0.01% | 1627 |
|
|
2022
Q4 | $107K | Buy |
27,212
+1,397
| +5% | +$5.52K | ﹤0.01% | 1639 |
|
|
2022
Q3 | $155K | Buy |
25,815
+1,045
| +4% | +$6.27K | ﹤0.01% | 1460 |
|
|
2022
Q2 | $160K | Sell |
24,770
-10,943
| -31% | -$70.7K | ﹤0.01% | 1525 |
|
|
2022
Q1 | $295K | Sell |
35,713
-9,743
| -21% | -$80.5K | ﹤0.01% | 1641 |
|
|
2021
Q4 | $704K | Buy |
45,456
+34,390
| +311% | +$533K | ﹤0.01% | 1231 |
|
|
2021
Q3 | $249K | Buy |
+11,066
| New | +$249K | ﹤0.01% | 1677 |
|